Clinical Trial Update: ICG and SLN Mapping [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update reporting results from a Phase 1 study evaluating indocyanine green (ICG) for sentinel lymph node mapping in breast cancer; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-08-15